In 2019 I met a Commercial Director who was deeply proud: 90% of his network had hit 110% of the annual quota target. The sales convention was a resounding success, with awards, speeches and photos for the company's LinkedIn. Six months later, the CFO revealed the hard truth in a board meeting: the division's net margin had dropped 5%.

Once you looked closely, the cause was simple. To hit the quota figure, reps had flooded low-value peripheral accounts — the easiest to convince — with discounts and overstock, while high-potential strategic accounts, which required longer and more complex negotiation cycles, went underserved. The incentive plan rewarded raw quantity, not margin quality. And commercial teams, like any rational people, respond mathematically to the structure of their variable pay — not to what the company preaches at the annual convention.

In my previous article I wrote about how SFE Augmented replaces intuition with mathematical precision in the commercial route — dynamic territories, predictive CRM, real cost per visit. But there's an uncomfortable truth that first article left open: no route algorithm survives a badly designed incentive. You can build the most sophisticated deployment system on the market — if your team's variable pay still rewards blind volume, your network will ignore the algorithm and chase the easy number instead. This article closes that missing piece.

The diagnosis: the fallacy of the traditional model

The vast majority of commercial incentive schemes calculate variable pay with a deceptively simple rule: Actual Sales / Target. It's easy to explain, easy to calculate, and easy to defend in front of a board. It's also, almost always, the silent reason margin erodes without anyone noticing until it's too late.

This rule overlooks three critical factors:

The latent analytical potential of each territory. The formula doesn't measure how much of the market's real potential has been captured — only how much was sold against a historical, often arbitrary, figure.

The complexity of opening large accounts versus inertial maintenance. Since the rule rewards total euro volume alone, a rational rep will prefer twenty easy visits over weeks spent closing a complex strategic account. It rewards the easy path, not strategic value.

The real contribution to margin (EBITDA). Not every product in a portfolio carries the same margin, and closing sales under the traditional model often means leaning on discounts, promotions or aggressive credit terms that never show up in "how much you sold" — only in the P&L three months later.

The theory: the Augmented Variable Triangle

In an SFE Augmented model, the incentive stops being a flat figure calculated at month-end and becomes a weighted vector function:

Total Variable = x1 + x2 + x3

x1 — Strategic value in key accounts. Rewards real penetration in high-potential (Target A) accounts, not inertial volume in easy accounts.

x2 — Digital interaction integration. Rewards reps who feed the CRM with their clients' prior digital signals — the same data that, as we saw in the previous article, triggers the in-person visit at exactly the right moment.

x3 — Margin protection. Rewards those who avoid abusing aggressive commercial terms — discounts, rebates or off-policy financing — that erode EBITDA even when the sale "counts" the same on the spreadsheet.

Replacing intuition with explicit mathematical rules isn't just a matter of financial rigor. It removes the perception of arbitrariness within the team, aligns variable pay with the company's finance direction, and — this is the part that took me longest to learn — dramatically reduces the loss of your best people.

A note on the case below The comparative example in the next section uses two fictional organizations — "StockPharma" and "EPSL-Bio" — the same ones from the previous article, built to illustrate, with coherent figures, the difference between a traditional incentive model and an SFE Augmented one. This is not real client data; it is a pedagogical exercise, treated as such.

Illustrative case: the talent loss nobody saw coming

Two pharmaceutical sales networks, same number of reps (70), same target market in cardiology. Radically opposite results in talent retention and market penetration.

StockPharma — linear plan
  • Incentive based solely on volume accumulated by postal code (Sell-In).
  • Reps in consolidated zones hit bonus easily with low-margin product.
  • Top reps, stuck in complex negotiations at major hubs, missed the threshold.
  • Result: 12% loss of top commercial talent in 6 months.
EPSL-Bio — Augmented Variable
  • Dynamic targets adjusted via Machine Learning based on each territory's real potential.
  • Weighted variable (x1+x2+x3) aligned with finance leadership.
  • 0% loss of key talent over the same period.
  • +25% penetration in major hospitals, +20% EBITDA on the flagship product.

A poorly designed incentive system doesn't just erode margin — it subsidizes the inertia of the "easy push" and ends up driving away the very professionals who could add the most value to the company. Algorithmic precision in setting variable pay is, at once, the best tool for talent retention and margin protection.

Why this piece closes the system

SFE Augmented isn't a tool for policing reps — it's a system that connects three things rarely designed together: field effort (the previous article), the team's real motivation (this article), and protection of the company's net margin. Optimizing only one of the three pieces — the route without the incentive, or the incentive without the route — leaves the system lame. Both have to be designed as a single commercial governance architecture.

Executive close: three questions for the Commercial Director